Timolol and Lung neoplasm malignant - a phase IV clinical study of FDA data

Summary:

Lung neoplasm malignant is reported as a side effect among people who take Timolol (timolol), especially for people who are male, 60+ old, also take Spiriva, and have Diabetic neuropathy.

The phase IV clinical study analyzes which people have Lung neoplasm malignant when taking Timolol. It is created by eHealthMe based on reports of 9,083 people who have side effects when taking Timolol from the FDA, and is updated regularly.

What is Timolol?

Timolol has active ingredients of timolol. It is often used in glaucoma. eHealthMe is studying from 9,142 Timolol users. Check the latest studies of Timolol.

What is Lung neoplasm malignant?

Lung neoplasm malignant (cancer tumour of lung) is found to be associated with 1,149 drugs and 926 conditions by eHealthMe. Check the latest studies of Lung neoplasm malignant.

On Jul, 16, 2026

9,083 people reported to have side effects when taking Timolol.
Among them, 12 people (0.13%) have Lung neoplasm malignant.

Could Timolol cause Lung neoplasm malignant?

Among these 12 people:

What is the gender of people who have Lung neoplasm malignant when taking Timolol? *

female: 50 %
male: 50 %

What is the age of people who have Lung neoplasm malignant when taking Timolol? *

What are other drugs people take besides Timolol? *

What are other side effects people have besides Lung neoplasm malignant? *

Arrhythmias (irregular heartbeat): 2 people, 16.67%
Atelectasis (partial or complete collapse of the lung): 2 people, 16.67%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 16.67%
Fatigue (feeling of tiredness): 2 people, 16.67%
Wound: 1 person, 8.33%
Dizziness: 1 person, 8.33%
Head Injury: 1 person, 8.33%
Haematuria (presence of blood in urine): 1 person, 8.33%
Gastrointestinal Sounds Abnormal: 1 person, 8.33%
Gastrointestinal Motility Disorder (abnormal intestinal contractions): 1 person, 8.33%

What are the existing conditions these people have? *

Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 4 people, 33.33%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 25.00%
Pain: 3 people, 25.00%
Multiple Myeloma (cancer of the plasma cells): 2 people, 16.67%
High Blood Pressure: 2 people, 16.67%
Diabetes: 2 people, 16.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 16.67%
Depression: 1 person, 8.33%
Essential Hypertension (primary hypertension): 1 person, 8.33%
Enlarged Prostate: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Timolol and have Lung neoplasm malignant?

- Check whether Lung neoplasm malignant is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Timolol:

Timolol (9,142 reports)

Browse all side effects of Timolol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Lung neoplasm malignant:

Lung neoplasm malignant (1,150 drugs)

Browse all the conditions that are associated with Lung neoplasm malignant:

Lung neoplasm malignant (926 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on timolol (the active ingredients of Timolol) and Timolol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.